Among the non-motor symptoms of Parkinson’s disease, cognitive and behavioral challenges also can be troubling and disabling. Medication, surgery, and other therapies can help alleviate motor symptoms, but the treatment of mental changes lags behind. Addressing cognitive, behavioral, emotional, and other neuropsychiatric issues may be daunting both for physicians and for the people with Parkinson’s whom they treat. Through a Parkinson’s Foundation grant, Dr. Jennifer Goldman has set up an Integrated Cognitive Behavioral Movement Disorder Program at Rush University Medical Center in Chicago, a Parkinson’s Foundation Center of Excellence. Its mission is to support people with PD and their care partners who need to treat and cope with non-motor as well as motor symptoms of the disease. She discusses some of the care challenges and offers advice for ways to address them.
- Understanding Parkinson’s: Cognitive Changes
- Cognitive Issues: Advice for Parkinson’s Care Partners (webinar)
- Cognition (book)
For all of our Substantial Matters podcast episodes, visit parkinson.org/podcast.
About This Episode
Released: April 24, 2018
Jennifer G. Goldman, MD, MS
Dr. Jennifer Goldman is an Associate Professor in the Department of Neurological Sciences, Section of Parkinson’s Disease and Movement Disorders at Rush University Medical Center in Chicago. Dr. Goldman is a fellowship trained movement disorder neurologist with specialty training and board certification in behavioral neurology and neuropsychiatry. Her clinical and research work focuses on understanding and improving treatments for cognitive and behavioral features of Parkinson’s disease, parkinsonian disorders, A progressive, neurodegenerative disease that shares symptoms of both Alzheimer’s disease and Parkinson’s. Unlike Parkinson’s disease dementia, cognitive symptoms are present before or within one year of noticing movement symptoms. The central features of DLB include progressive cognitive decline, changes in alertness and attention, visual hallucinations and parkinsonian motor symptoms such as slowness of movement, difficulty walking or rigidity., and other movement disorders using advanced neuroimaging, genetics, and other biomarkers. Dr. Goldman graduated from Princeton University and received her MD from Northwestern University Medical School. She completed her neurology residency training at Washington University in St. Louis, followed by a movement disorder fellowship and a Master of Science degree in clinical research at Rush University in Chicago. She is board certified by the American Board of Neurology and Psychiatry.
As a movement disorder specialist, Goldman treats patients with Parkinson’s disease, atypical parkinsonian disorders, dementia with Lewy bodies, dystonia, and other movement-related conditions in the clinic. She directs the Cognitive-Behavioral program within the Section of Movement Disorders. Her research has been funded by NIH, Michael J. Fox Foundation, Rush University, Parkinson’s Disease Foundation, National Parkinson Foundation, among others. She has published multiple research articles and book chapters on Parkinson’s disease, cognition, behavior, and other movement disorders. She is a Fellow of the American Academy of Neurology and American Neurological Association. Goldman has chaired or served on working groups for biomarkers, cognition/psychiatry and Parkinson’s disease mild cognitive impairment for the Parkinson’s Study Group and the Movement Disorders Society (MDS). She also serves on the Lewy Body Dementia Association Scientific Advisory Committee and the Dystonia Foundation’s Medical Advisory Committee for Musicians with Dystonia. Goldman also is active in education and mentorship at Rush and in the neurological societies.
She was the 2013 recipient of the Rush University Faculty Award for Excellence in Education and has lectured nationally and internationally. She serves on the AAN Education Committee, MDS Leadership Task Force, and as chair of the MDS Pan-American Section Education Committee.